Returns | 1W : 4.6% , 1M : 8.5%,1Y : 103% |
LT :   |
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : High |
ST :   |
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward Pledged Shares : None or < 25% |
Peers & Returns | 1W | 1M | 1Y |
GRANULES INDIA | 4.6% | 8.5% | 103% |
SUN PHARMACEUTICAL INDUSTRIES | 1.2% | 11.4% | 36.3% |
DR REDDYS LABORATORIES | 7.4% | 23.5% | 34.1% |
DIVIS LABORATORIES | -0.8% | 14.8% | 61.7% |
CIPLA | 3.3% | 25.1% | 62.3% |
BIOCON | -1.2% | 2.6% | 12.1% |
AUROBINDO PHARMA | 8.6% | 23.1% | 82.7% |
LUPIN | 1.1% | 6.1% | 34.7% |
TORRENT PHARMACEUTICALS | 0.4% | 8.8% | 11.6% |
Ratio | Value |
---|---|
P/E P/B P/S |
25.17
P/E Calculated based on EPS of 13.19
[ Mar2020 - Consolidated Results ] 4.62
P/B Calculated based on Book Value of 71.8
[ Mar2020 - Consolidated Results ] 2.84
P/S Calculated based on Revenues of 2897.56 Cr
[ TTM - Consolidated Results ] |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
68% 52% 92% |
Pledged Shares |
8.64 % |
---|---|
As on : Sep2020 | |
If less than 25% | Good |
If between 25% and 50% | Neutral |
If greater than 50% | Bad |
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE HEALTHCARE | 3.7% | 15.3% | 56.9% |
S&P BSE SMALL CAP | 0.5% | 2.5% | 90.8% |
S&P BSE MIDSMALLCAP | 0.2% | 1.7% | 80% |
S&P BSE 400 MIDSMALLCAP | 0% | 1% | 81% |
S&P BSE 250 SMALLCAP | -0.2% | 0.1% | 87.8% |
S&P BSE ALLCAP | -0.8% | -0.3% | 59.7% |
S&P BSE 500 | -0.9% | -0.4% | 58.8% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY SMALLCAP 50 | 1.1% | 0% | 109% |
NIFTY FREE SMALL 100 | 0.6% | 0.8% | 98.4% |
NIFTY SMALLCAP250 | 0.3% | 1% | 90.9% |
NIFTY MID SMALL400 | -0.1% | 0.9% | 80.8% |
NIFTY 500 | -0.9% | -0.4% | 58.3% |